Unique Ingredient Identifier 7T1F30V5YH is listed as a ingredient substance
RN | 9005-64-5 |
NCIT | C80937 |
RXCUI | 8559 |
MF | Polymer substance not supported |
UNII 7T1F30V5YH POLYSORBATE 20 is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.1 % |
IM - SC | INJECTION | 0.001 % |
INTRAMUSCULAR | INJECTABLE | 16.2 mg/1mL |
INTRAMUSCULAR | INJECTION | NA |
INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 0.5 % |
INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.01 % |
INTRAMUSCULAR | SOLUTION, INJECTION | 0.029 %W/V |
INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 1 % |
INTRAMUSCULAR | SUSPENSION, INJECTION | 1.8 % |
INTRAVENOUS | INJECTABLE | 10 mg/mL |
INTRAVENOUS | INJECTION | 4.8 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.044 % |
INTRAVENOUS | SOLUTION, INJECTION | 1 % |
IV(INFUSION) | INJECTABLE | 0.003 % |
IV(INFUSION) | INJECTION | 2.4 % |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 0.023 % |
IV(INFUSION) | SOLUTION, INJECTION | 0.003 % |
NASAL | SPRAY, METERED | 2.5 % |
OPHTHALMIC | SUSPENSION | 0.05 % |
OPHTHALMIC | SUSPENSION, DROPS | NA |
ORAL | CAPSULE | 56.25 MG |
ORAL | POWDER, FOR SUSPENSION | 1.3 MG/5ML |
ORAL | SOLUTION, ELIXIR | NA |
ORAL | SUSPENSION | 5 MG/1ML |
ORAL | TABLET | 6 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 0.35 MG |
ORAL | TABLET, COATED | NA |
ORAL | TABLET, EXTENDED RELEASE | 4.2 MG |
ORAL | TABLET, FILM COATED | NA |
SUBCUTANEOUS | INJECTABLE | 0.003 % |
SUBCUTANEOUS | INJECTION | 0.001 % |
SUBCUTANEOUS | LIQUID | 0.05 % |
SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.01 % |
SUBCUTANEOUS | SOLUTION, INJECTION | 0.2 % |
TOPICAL | EMULSION | 2 %W/W |
TOPICAL | EMULSION, AEROSOL FOAM | 3.7 %W/W |
TOPICAL | EMULSION, CREAM | 0.8 %W/W |
TOPICAL | GEL | 5 %W/W |
TOPICAL | LOTION | 7.8 %W/W |
TOPICAL | SOLUTION | 15 %W/W |
VAGINAL | SUPPOSITORY | NA |
VAGINAL | TAMPON | 64.8 MG |